Literature DB >> 20031891

Patient registries of acute coronary syndrome: assessing or biasing the clinical real world data?

Ignacio Ferreira-González1, Josep R Marsal, Francesca Mitjavila, Antoni Parada, Aida Ribera, Purificación Cascant, Núria Soriano, Pedro L Sánchez, Fernando Arós, Magda Heras, Héctor Bueno, Jaume Marrugat, José Cuñat, Emilia Civeira, Gaietà Permanyer-Miralda.   

Abstract

BACKGROUND: The risk of selection bias in registries and its consequences are relatively unexplored. We sought to assess selection bias in a recent registry about acute coronary syndrome and to explore the way of conducting and reporting patient registries of acute coronary syndrome. METHODS AND
RESULTS: We analyzed data from patients of a national acute coronary syndrome registry undergoing an audit about the comprehensiveness of the recruitment/inclusion. Patients initially included by hospital investigators (n=3265) were compared to eligible nonincluded (missed) patients (n=1439). We assessed, for 25 exposure variables, the deviation of the in-hospital mortality relative risks calculated in the initial sample from the actual relative risks. Missed patients were of higher risk and received less recommended therapies than the included patients. In-hospital mortality was almost 3 times higher in the missed population (9.34% [95% CI, 7.84 to 10.85] versus 3.9% [95% CI, 2.89 to 4.92]). Initial relative risks diverged from the actual relative risks more than expected by chance (P<0.05) in 21 variables, being higher than 10% in 17 variables. This deviation persisted on a smaller degree on multivariable analysis. Additionally, we reviewed a sample of 129 patient registries focused on acute coronary syndrome published in thirteen journals, collecting information on good registry performance items. Only in 38 (29.4%) and 48 (37.2%) registries was any audit of recruitment/inclusion and data abstraction, respectively, mentioned. Only 4 (3.1%) authors acknowledged potential selection bias because of incomplete recruitment.
CONCLUSIONS: Irregular inclusion can introduce substantial systematic bias in registries. This problem has not been explicitly addressed in a substantial number of them.

Entities:  

Mesh:

Year:  2009        PMID: 20031891     DOI: 10.1161/CIRCOUTCOMES.108.844399

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  10 in total

1.  Race and gender differences in 1-year outcomes for community-dwelling stroke survivors with family caregivers.

Authors:  David L Roth; William E Haley; Olivio J Clay; Martinique Perkins; Joan S Grant; J David Rhodes; Virginia G Wadley; Brett Kissela; George Howard
Journal:  Stroke       Date:  2011-01-21       Impact factor: 7.914

2.  Risk Factors for 1-Year Graft Loss After Kidney Transplantation: Systematic Review and Meta-Analysis.

Authors:  Farid Foroutan; Erik Loewen Friesen; Kathryn Elizabeth Clark; Shahrzad Motaghi; Roman Zyla; Yung Lee; Rakhshan Kamran; Emir Ali; Mitch De Snoo; Ani Orchanian-Cheff; Christine Ribic; Darin J Treleaven; Gordon Guyatt; Maureen O Meade
Journal:  Clin J Am Soc Nephrol       Date:  2019-09-20       Impact factor: 8.237

3.  Apples to apples or apples to oranges? International variation in reporting of process and outcome of care for out-of-hospital cardiac arrest.

Authors:  Chika Nishiyama; Siobhan P Brown; Susanne May; Taku Iwami; Rudolph W Koster; Stefanie G Beesems; Markku Kuisma; Ari Salo; Ian Jacobs; Judith Finn; Fritz Sterz; Alexander Nürnberger; Karen Smith; Laurie Morrison; Theresa M Olasveengen; Clifton W Callaway; Sang Do Shin; Jan-Thorsten Gräsner; Mohamud Daya; Matthew Huei-Ming Ma; Johan Herlitz; Anneli Strömsöe; Tom P Aufderheide; Siobhán Masterson; Henry Wang; Jim Christenson; Ian Stiell; Dan Davis; Ella Huszti; Graham Nichol
Journal:  Resuscitation       Date:  2014-07-08       Impact factor: 5.262

4.  Cardiac arrest risk standardization using administrative data compared to registry data.

Authors:  Anne V Grossestreuer; David F Gaieski; Michael W Donnino; Joshua I M Nelson; Eric L Mutter; Brendan G Carr; Benjamin S Abella; Douglas J Wiebe
Journal:  PLoS One       Date:  2017-08-04       Impact factor: 3.240

5.  Public health surveillance of automated external defibrillators in the USA: protocol for the dynamic automated external defibrillator registry study.

Authors:  JoAnn Broeckel Elrod; Raina Merchant; Mohamud Daya; Scott Youngquist; David Salcido; Terence Valenzuela; Graham Nichol
Journal:  BMJ Open       Date:  2017-03-29       Impact factor: 2.692

6.  Patient Registries: An Underused Resource for Medicines Evaluation : Operational proposals for increasing the use of patient registries in regulatory assessments.

Authors:  Patricia McGettigan; Carla Alonso Olmo; Kelly Plueschke; Mireia Castillon; Daniel Nogueras Zondag; Priya Bahri; Xavier Kurz; Peter G M Mol
Journal:  Drug Saf       Date:  2019-11       Impact factor: 5.606

7.  Validating Acute Myocardial Infarction Diagnoses in National Health Registers for Use as Endpoint in Research: The Tromsø Study.

Authors:  Torunn Varmdal; Ellisiv B Mathiesen; Tom Wilsgaard; Inger Njølstad; Audhild Nyrnes; Sameline Grimsgaard; Kaare Harald Bønaa; Jan Mannsverk; Maja-Lisa Løchen
Journal:  Clin Epidemiol       Date:  2021-08-03       Impact factor: 4.790

8.  Interrater reliability of a national acute myocardial infarction register.

Authors:  Ragna Elise Støre Govatsmark; Sylvi Sneeggen; Hanne Karlsaune; Stig Arild Slørdahl; Kaare Harald Bønaa
Journal:  Clin Epidemiol       Date:  2016-08-17       Impact factor: 4.790

Review 9.  Quality markers in cardiology: measures of outcomes and clinical practice--a perspective of the Spanish Society of Cardiology and of Thoracic and Cardiovascular Surgery.

Authors:  José-Luis López-Sendón; José Ramón González-Juanatey; Fausto Pinto; José Cuenca Castillo; Lina Badimón; Regina Dalmau; Esteban González Torrecilla; José Ramón López Mínguez; Alicia M Maceira; Domingo Pascual-Figal; José Luis Pomar Moya-Prats; Alessandro Sionis; José Luis Zamorano
Journal:  Eur Heart J       Date:  2015-10-21       Impact factor: 29.983

10.  Methods for external control groups for single arm trials or long-term uncontrolled extensions to randomized clinical trials.

Authors:  John D Seeger; Kourtney J Davis; Michelle R Iannacone; Wei Zhou; Nancy Dreyer; Almut G Winterstein; Nancy Santanello; Barry Gertz; Jesse A Berlin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-10-04       Impact factor: 2.890

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.